Clinical features of GATA2 deficiency syndrome
Clinical feature . | Percentage of patients . |
---|---|
Hematologic | |
Cytopenias | |
B cell | 86 |
NK cell | 82 |
Monocytopenia | 78 |
CD4 | 51 |
Neutropenia | 47 |
Malignant blood disorders | |
MDS* | 84 |
AML | 14 |
CMML | 8 |
Infectious | |
Viral | 70 |
HPV | 63 |
Herpesvirus | 35 |
Herpes simplex virus | 16 |
Varicella Zoster virus | 11 |
EBV | 11 |
Cytomegalovirus | 4 |
Molloscum contagiosum | 3.5 |
Bacterial | |
Disseminated nontubercular mycobacteria† | 53 |
Other severe bacterial | 49 |
Severe fungal | 16 |
Aspergillosis | 9 |
Histoplasmosis | 5 |
Candidiasis | 5 |
Solid tumors | |
HPV-related neoplasia | 35 |
EBV-related neoplasia‡ | |
Breast cancer§ | 22 |
Pulmonary | |
Pulmonary alveolar proteinosis | 18 |
Pulmonary function test abnormalities | 79 |
Lymphedema | 11 |
Venous thrombosis | 25 |
Mild to severe sensorineuronal hearing loss|| | 76 |
Miscarriage¶ | 33 |
Hypothyroidism | 14 |
Clinical feature . | Percentage of patients . |
---|---|
Hematologic | |
Cytopenias | |
B cell | 86 |
NK cell | 82 |
Monocytopenia | 78 |
CD4 | 51 |
Neutropenia | 47 |
Malignant blood disorders | |
MDS* | 84 |
AML | 14 |
CMML | 8 |
Infectious | |
Viral | 70 |
HPV | 63 |
Herpesvirus | 35 |
Herpes simplex virus | 16 |
Varicella Zoster virus | 11 |
EBV | 11 |
Cytomegalovirus | 4 |
Molloscum contagiosum | 3.5 |
Bacterial | |
Disseminated nontubercular mycobacteria† | 53 |
Other severe bacterial | 49 |
Severe fungal | 16 |
Aspergillosis | 9 |
Histoplasmosis | 5 |
Candidiasis | 5 |
Solid tumors | |
HPV-related neoplasia | 35 |
EBV-related neoplasia‡ | |
Breast cancer§ | 22 |
Pulmonary | |
Pulmonary alveolar proteinosis | 18 |
Pulmonary function test abnormalities | 79 |
Lymphedema | 11 |
Venous thrombosis | 25 |
Mild to severe sensorineuronal hearing loss|| | 76 |
Miscarriage¶ | 33 |
Hypothyroidism | 14 |
Percentage of patients manifesting noted clinical features. Data abstracted from Spinner et al95 from 57 patients, 40 of whom were diagnosed on the basis of clinical presentation, with an additional 17 through family screening. Similar data are tabulated by Collin et al.6
CMML, chronic myelomonocytic leukemia; EBV, Epstein-Barr virus; HPV, human papillomavirus.
Of 50 patients who underwent bone marrow biopsy.
Reflects potential ascertainment bias before clinical phenotype expanded.
Per Cohen et al.92
Of 18 women ≥35 years old, including one with a concurrent BRCA2 mutation.
Not controlled for aminoglycoside exposure for treatment of bacterial infections.
Of 43 known pregnancies.